The hCtr1 expression level may be related to the aggressiveness or prognosis of the prostate cancer and to the response of prostate cancer to cisplatin chemotherapy because hCtr1 was recently reported to be able to mediate cellular uptake of cisplatin [62]. This evidence concerns the gene SLC31A1 and prostate cancer.